Karl Tobieson (Born 1974)
Chief Executive Officer since 2008.
Education: MSc Industrial Management, KTH Royal Institute of Technology.
Other current positions: Chairman Tobieson & Svennewall Aktiebolag. Director T&S förvaltning AB. Deputy Director OGGroup AB, Gram Medicin AB.
Previous positions (past five years): Chairman IM-Medico Svenska AB and Lurbo Fastighets AB. Director Medistesia AB, Specialistapoteket Sverige AB and Real Option i Sverige 31 AB.
Holdings: Karl Tobieson holds 720,651 shares including related-party holdings in MedCap.
Other current positions: Chairman Tobieson & Svennewall Aktiebolag. Director T&S förvaltning AB. Deputy Director OGGroup AB, Gram Medicin AB.
Previous positions (past five years): Chairman IM-Medico Svenska AB and Lurbo Fastighets AB. Director Medistesia AB, Specialistapoteket Sverige AB and Real Option i Sverige 31 AB.
Holdings: Karl Tobieson holds 720,651 shares including related-party holdings in MedCap.
Henrik Koch (Born 1973)
Chief Financial Officer since 2018.
Education: MSc Chemical technology, KTH (Royal Institute of Technology). MSc Economics and Business Administration, Stockholm School of Economics.
Other current positions: None.
Previous positions (past five years): CFO HectorRail AB.
Holdings: None.
Other current positions: None.
Previous positions (past five years): CFO HectorRail AB.
Holdings: None.
Thomas Bergh (Born 1982)
Investment Manager since 2016
Education: MSc Economics and Business Administration, Stockholm School of Economics.
Previous positions (past five years): Vice President Morgan Stanley and Analyst/Associate UBS Investment Bank.
Holdings: Thomas Bergh holds 25,000 shares in MedCap.
Previous positions (past five years): Vice President Morgan Stanley and Analyst/Associate UBS Investment Bank.
Holdings: Thomas Bergh holds 25,000 shares in MedCap.